UNSPSC 51283945: Sulfadiazine silver

This classification denotes a topical anti-infective agent and sulfonamide anti-infective agent with the molecular formula C10H9N4O2S.Ag, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W46JY43EJR, chemically known as sulfanilamide, n(sup 1)-2-pyrimidinyl-, monosilver(1+) salt but more generally known as silver sulfadiazine, which bears US NIH Compound Identifier 31011. European Medicines Agency schedules Silver sulfadiazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04622MIG.

World Health Organization schedules silver sulfadiazine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule sulfadiazine silver under HS 29350090 and SITC 51580. SMILES: C1CNC(NC1)[N-]S(=O)(=O)C2CCC(CC2)N.[AG+].

UNSPSC 51283945 Sulfadiazine silver is a Commodity code that nominally designates a topical antimicrobial wound-care product, but recent state and local opportunities tagged under this code show no purchases of sulfadiazine silver itself. Instead, the solicitations span emergency medical supplies, naloxone and drug deactivation systems, generic pharmaceuticals and OTC products, and direct-to-manufacturer prescription programs — a misalignment between the code's nominal scope and actual procurement activity. State and local jurisdictions posting under this code include county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances. The City of Tampa Fire Department and Seminole County, Florida have solicited emergency response and community health supplies; Texas HHS Commission has issued a Request for Information on pharmacy benefit management; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) has sought generic pharmaceuticals and OTC products for distribution across participating states including Oregon. The code shows little relevant recent activity aligned with its stated product definition, suggesting that sulfadiazine silver procurement either falls under alternative UNSPSC codes or represents a minimal share of state and local medical-supply purchasing.

Recent opportunities under this code span Florida, Texas, and Minnesota through both individual jurisdictions and cooperative purchasing vehicles. Seminole County's IFB 60459723LAS (response due July 26, 2026) seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The City of Tampa's IFB 26-P-00145 (response due March 13, 2026) solicited 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000 and an SLBE set-aside, awarded to the lowest responsive, responsible bidder. The Minnesota Department of Administration's MMCAP issued an RFP (response due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be supplied through three authorized wholesalers effective July 1, 2026. Texas HHS Commission posted an RFI (HHS0017013, posted April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription programs. Given the mismatch between the code's product definition and the actual solicitations, vendors pursuing sulfadiazine silver sales should verify code assignment before responding.